PARIS (Reuters) - Sanofi said on Monday that a late-stage clinical study showed that its dengue vaccine candidate met its main goal and was highly effective against severe cases of the disease. The French drugmaker's Sanofi Pasteur division intends to file for registration for the vaccine in several endemic countries next year, it said in a statement. "Subject to regulatory approval, the world's first dengue vaccine could be available in the second half of 2015," Sanofi said. The Phase III study involved 31,000 participants across 10 endemic countries in Asia and Latin America, Sanofi said. ...
via Health News Headlines - Yahoo News http://ift.tt/1tUdfCg
via Health News Headlines - Yahoo News http://ift.tt/1tUdfCg
No comments:
Post a Comment